Factors that may influence the choice for initiating apremilast or methotrexate treatment for psoriasis in real-world clinical setting

被引：1

作者：

Fougerousse, A. -C. ^{[1
]}

Maccari, F. ^{[2
]}

Beauchet, A. ^{[3
,4
]}

Parier, J. ^{[2
]}

Boulard, C. ^{[5
]}

Becherel, P. -A. ^{[6
]}

Quiles-Tsimaratos, N. ^{[7
]}

Le Guyadec, T. ^{[8
]}

Thomas-Beaulieu, D. ^{[9
]}

Halioua, B. ^{[10
]}

Begon, E. ^{[11
]}

Bastien, M. ^{[12
]}

Perrot, J. -L. ^{[13
]}

Pallure, V. ^{[14
]}

Bilan, P. ^{[15
]}

Steff, M. ^{[15
]}

Pfister, P. ^{[10
]}

Vermersch-Langlin, A. ^{[16
]}

Boye, T. ^{[17
]}

Mery-Bossard, L. ^{[18
]}

Maillard, H. ^{[19
]}

Kemula, M. ^{[10
]}

Girard, C. ^{[20
]}

Poiraud, C. ^{[21
]}

Monfort, J. -B. ^{[22
]}

Kupfer-Bessaguet, I. ^{[23
]}

Perrussel, M. ^{[24
]}

Lons-Danic, D. ^{[25
]}

Sultan, N. ^{[26
]}

Lorier, E. ^{[10
]}

Zeitoun, M. ^{[27
]}

Wagner, L. ^{[10
]}

Gabison, G. ^{[28
]}

Mahe, E. ^{[29
]}

机构：

[1] Hop Instruct Armees Begin, Dept Dermatol, St Mande, France

[2] Private Off, La Varenne St Hilaire, France

[3] Univ Paris Saclay, CHU Ambroise Pare, AP HP, Dept Publ Hlth, Boulogne, France

[4] Univ Paris Saclay, UVSQ, Boulogne, France

[5] Hop Havre, Dept Dermatol, Montivilliers, France

[6] Hop Prive Antony, Dept Dermatol, Antony, France

[7] Hop St Joseph, Dept Dermatol, Marseille, France

[8] Hop Instruct Armees Percy, Dept Dermatol, Clamart, France

[9] Ctr Hosp Intercommunal Poissy St Germain Laye, Dept Dermatol, Poissy, France

[10] Private Off, Paris, France

[11] Hop Rene Dubos, Dept Dermatol, Pontoise, France

[12] Private Off, Joinville Le Pont, France

[13] CHU St Etienne, Dept Dermatol, St Etienne, France

[14] Ctr Hosp, Dept Dermatol, Perpignan, France

[15] Ctr Hosp Robert Ballanger, Dept Dermatol, Aulnay Sous Bois, France

[16] Ctr Hosp, Dept Dermatol, Valenciennes, France

[17] Hop Instruct Armees St Anne, Dept Dermatol, Toulon, France

[18] Ctr Hosp Francois Quesnay, Dept Dermatol, Mantes La Jolie, France

[19] Ctr Hosp, Dept Dermatol, Le Mans, France

[20] CHU St Eloi, Dept Dermatol, Montpellier, France

[21] Ctr Hosp, Dept Dermatol, La Roche Sur Yon, France

[22] CHU Tenon, Dept Dermatol, Paris, France

[23] Ctr Hosp, Dept Dermatol, Niort, France

[24] Private Off, Auray, France

[25] Hop St Joseph, Dept Dermatol, Paris, France

[26] Ctr Hosp Gabriel Martin, Dept Dermatol, St Paul, France

[27] Private Off, Antony, France

[28] Private Off, St Maurice, France

[29] Hop Victor Dupouy, Dept Dermatol, Argenteuil, France

来源：

JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY | 2019年 / 33卷 / 12期

关键词：

EXPERIENCE; SURVIVAL;

D O I：

10.1111/jdv.15804

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

引用

页码：E476 / E478

页数：3

共 50 条

[31] Treatment satisfaction, safety and effectiveness of adding methotrexate to adalimumab in patients with psoriasis responding suboptimally to adalimumab in a real-world setting
Papp, K. A.
Gooderham, M. J.
Albrecht, L. E.
Raymond, M. -A.
Lynde, C. W.
BRITISH JOURNAL OF DERMATOLOGY, 2022, 186 (04) : 726 - 728
[32] Design a Clinical Research Protocol: Influence of Real-World Setting
Cimino, Jonathan
Braun, Claude
HEALTHCARE, 2023, 11 (16)
[33] Real-World Apremilast Use for Treatment of Plaque Psoriasis in Italy: Patient Perspective, Characteristics, and Clinical Outcomes from the DARWIN Study
Giofre, Claudia
Fabbrocini, Gabriella
Potenza, Concetta
Tiberio, Rossana
Gisondi, Paolo
Marasca, Claudio
Nuzzo, Carmen M. A.
Benincasa, Emiliana
Bianchi, Luca
ADVANCES IN THERAPY, 2023, 40 (07) : 3021 - 3037
[34] Real-World Apremilast Use for Treatment of Plaque Psoriasis in Italy: Patient Perspective, Characteristics, and Clinical Outcomes from the DARWIN Study
Claudia Giofrè
Gabriella Fabbrocini
Concetta Potenza
Rossana Tiberio
Paolo Gisondi
Claudio Marasca
Carmen M. A. Nuzzo
Emiliana Benincasa
Luca Bianchi
Advances in Therapy, 2023, 40 : 3021 - 3037
[35] Real-world drug survival and reasons for treatment discontinuation of biologics and apremilast in patients with psoriasis in an academic center
Zeb, Lawangeen
Mhaskar, Rahul
Lewis, Suzanna
Patel, Nishit S.
Sadhwani, Divya
Patel, Nupur
Ekhlassi, Erfon
Lu, Yuanyuan
Seminario-Vidal, Lucia
DERMATOLOGIC THERAPY, 2021, 34 (02)
[36] Drug survival of secukinumab for psoriasis in a real-world setting
Lee, Erica B.
Amin, Mina
Egeberg, Alexander
Wu, Jashin J.
JOURNAL OF DERMATOLOGICAL TREATMENT, 2019, 30 (02) : 150 - 151
[37] Real-world experience with apremilast for the treatment of psoriasis: Retrospective single-center study in the Canary Islands
Lukoviek, V.
Arteaga-Henriquez, M.
Ramirez-Conchas, J.
Markthaler, M.
Pestana-Eliche, M.
Garcia-Bustinduy, M.
Guimera-Martin-Neda, F.
Perez-Robayna, N.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2019, 81 (04) : AB115 - AB115
[38] Real-world data on the efficacy and safety of apremilast in Japanese patients with plaque psoriasis
Ohata, Chika
Ohyama, Bungo
Kuwahara, Fumi
Katayama, Eri
Nakama, Takekuni
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2019, 81 (04) : AB115 - AB115
[39] Real-World Insight on Apremilast Therapy in Patients with Plaque Psoriasis: Indian Experience
De, Abhishek
Das, Sudip
Dhoot, Dhiraj
Sarda, Aarti
INDIAN JOURNAL OF DERMATOLOGY, 2020, 65 (05) : 396 - 400
[40] Real-world data on the efficacy and safety of apremilast in Japanese patients with plaque psoriasis
Ohata, Chika
Ohyama, Bungo
Kuwahara, Fumi
Katayama, Eri
Nakama, Takekuni
JOURNAL OF DERMATOLOGICAL TREATMENT, 2019, 30 (04) : 383 - 386

← 1 2 3 4 5 →